4//SEC Filing
BELLICUM PHARMACEUTICALS, INC 4
Accession 0001358403-16-000239
CIK 0001358403operating
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 5:50 PM ET
Size
7.0 KB
Accession
0001358403-16-000239
Insider Transaction Report
Form 4
Slawin Kevin M.
DirectorCMO and CTO
Transactions
- Sale
Common Stock
2016-07-27$15.00/sh−15,000$225,000→ 399,982 total(indirect: By Trust)
Holdings
- 134,206
Common Stock
- 398,067(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 23, 2016 by the Reporting Person.
- [F2]The Reporting Person's spouse is trustee of the Jordana Slawin 2012 Family Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeoperating
Related Parties
1- filerCIK 0001358403
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 5:50 PM ET
- Size
- 7.0 KB